22/03/03 12:14:34.76 m8VWtvLb0.net
一方で今月発表されたイベルメクチン有効だという論文
Treatment with Ivermectin Is Associated with Decreased Mortality in
COVID-19 Patients: Analysis of a National Federated Database
//www.sciencedirect.c●om/science/article/pii/S1201971221009887#
There were a total of 1,761,060 possible COVID-19 patients based on ICD-10 diagnostic terms and confirmatory lab results.
Prior to controlling, our analysis yielded 41,608 patients who had COVID-19 resulting in two unique cohorts that were treated
with either ivermectin (1,072) or remdesivir (40,536). Within the ivermectin cohort, average age was 51.9?+?17.8 years, 43% were
male, 60% had glucocorticoids and 1% required ventilator support. In the remdesivir cohort, average age was 62.0?+?16.0 years,
54% were male, 64% had glucocorticoids and 2% required ventilator support. After using propensity score matching and
adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI
(0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.